Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Discover how to live successfully with one kidney through tips on protection, nutrition, and exercise. Learn the four ways ...

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.

Kidney disease ranges from mild dysfunction treatable with medication to severe cases requiring dialysis or transplant. Acute ...